Aydin Displays buys MegaScan

Article

The MegaScan line of monitors formerly sold by EMED found a new home after monitor manufacturer Aydin Displays acquired the business from Access Radiology. The deal should help Aydin expand into the healthcare business from its core activities in

The MegaScan line of monitors formerly sold by EMED found a new home after monitor manufacturer Aydin Displays acquired the business from Access Radiology. The deal should help Aydin expand into the healthcare business from its core activities in military and industrial displays. Terms of the deal were not disclosed.

Teleradiology firm EMED provided MegaScan monitors to PACS OEMs, and Access of Lexington, MA, acquired the line with its purchase of EMED in December (SCAN 11/25/98). Access sold the division to Aydin as part of a larger strategy of focusing on electronic medical imaging technology and systems, according to Scott Sheldon, Access CEO.

Although Aydin Displays has primarily developed CRT monitor technology for military and industrial applications, the Horsham, PA-based company has begun developing active matrix liquid crystal display (AMLCD) flat-panel technology for medical uses. The MegaScan deal offers Aydin a line of high-resolution medical imaging CRT monitors and gives MegaScan financial stability, according to Aydin.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.